Lantern Pharma (LTRN) Reports Q1 Loss of $0.51

Lantern Pharma (NASDAQ: LTRN) reported Q1 EPS of ($0.51).

For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• Morgan Stanley refreshes Strait of Hormuz reopening analysis
• Open-Medicine AI: Lantern Pharma to Present the Agentic AI Drug Development Market, User Needs, Development Roadmap, Platform Economics, and Benchmarks, Today at 12:30 PM ET